معرفی
Serge Lemay, MD is an Associate Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences, and serves as an Associate Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site. He is affiliated with the Department of Medicine, Division of Nephrology at the MUHC, where he leads research in the Metabolic Disorders and Complications Program within the Centre for Translational Biology.
Dr. Lemay's research primarily focuses on acute kidney injury (AKI), investigating the molecular basis of kidney cell injury and repair. His work centers on tyrosine kinases of the Src and Eph families and the role of intracellular scaffolding proteins like Dok-4 in regulating cellular responses triggered by these kinases. His research employs biochemical and whole animal approaches to identify therapeutic targets for reducing AKI severity or accelerating recovery.
His scholarly contributions span multiple disciplines within nephrology and molecular biology, with a consistent focus on cell signaling pathways in kidney disease. His publication record shows sustained research activity from 1999 through 2025, with recent work examining SGLT2 inhibitors, podocyte protection mechanisms, and advanced techniques for studying acute kidney injury.
Dr. Lemay collaborates extensively with researchers both within McGill University and internationally, as evidenced by his co-authorship on numerous publications. His work bridges basic molecular research with clinical applications in kidney disease, reflecting a strong translational research approach.
